Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9811
-0.0164 (-1.64%)
At close: Aug 13, 2025, 4:00 PM
0.9801
-0.0010 (-0.10%)
Pre-market: Aug 14, 2025, 8:19 AM EDT
Lucid Diagnostics Revenue
Lucid Diagnostics had revenue of $1.16M in the quarter ending June 30, 2025, with 19.16% growth. This brings the company's revenue in the last twelve months to $4.36M, up 14.74% year-over-year. In the year 2024, Lucid Diagnostics had annual revenue of $4.35M with 79.00% growth.
Revenue (ttm)
$4.36M
Revenue Growth
+14.74%
P/S Ratio
15.57
Revenue / Employee
$60,556
Employees
72
Market Cap
99.97M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LUCD News
- 16 hours ago - Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PRNewsWire
- 9 days ago - Lucid Diagnostics to Participate in Upcoming Investor Conferences - PRNewsWire
- 14 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 - PRNewsWire
- 15 days ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - PRNewsWire
- 15 days ago - PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 4 weeks ago - MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire
- 2 months ago - Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - PRNewsWire